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ABSTRACT
All DNA polymerases misincorporate ribonu-
cleotides despite their preference for deoxyribonu-
cleotides, and analysis of cultured cells indicates
that mammalian mitochondrial DNA (mtDNA) toler-
ates such replication errors. However, it is not clear
to what extent misincorporation occurs in tissues,
or whether this plays a role in human disease.
Here, we show that mtDNA of solid tissues contains
many more embedded ribonucleotides than that
of cultured cells, consistent with the high ratio of
ribonucleotide to deoxynucleotide triphosphates
in tissues, and that riboadenosines account for
three-quarters of them. The pattern of embedded
ribonucleotides changes in a mouse model of Mpv17
deficiency, which displays a marked increase in
rGMPs in mtDNA. However, while the mitochondrial
dGTP is low in the Mpv17−/− liver, the brain shows
no change in the overall dGTP pool, leading us
to suggest that Mpv17 determines the local con-
centration or quality of dGTP. Embedded rGMPs
are expected to distort the mtDNA and impede its
replication, and elevated rGMP incorporation is
associated with early-onset mtDNA depletion in
liver and late-onset multiple deletions in brain of
Mpv17−/− mice. These findings suggest aberrant
ribonucleotide incorporation is a primary mtDNA
abnormality that can result in pathology.
INTRODUCTION
Mammalian mitochondrial DNA (mtDNA) is a small co-
valently closed circular molecule of ∼16 kb, encoding 13
essential components of the oxidative phosphorylation sys-
tem (OXPHOS). OXPHOS provides the bulk of the cell’s
energy in the form of ATP, thus a reduction in the amount
(depletion) or quality of the mtDNA (ranging from point
mutations to multiple deletions) can cause an energy cri-
sis and human pathologies (1). A group of mtDNA disor-
ders result from defects in factors that alter deoxynucleotide
triphosphate (dNTP) homeostasis (2–4), one of which is
MPV17, a mitochondrial inner membrane protein whose
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loss of function causes a tissue-specific decrease of dGTP
and dTTP, which is associated withmtDNAdepletion (5,6).
A peculiar feature of mammalian mtDNA is the high
number of embedded ribonucleotides in comparison to nu-
clear DNA (7–9), which are scattered throughout both
strands of the mtDNA (7,10). Although an early study de-
tected no bias among the four ribonucleotides (11), more
recently rCMP and rGMP were found to be dispropor-
tionately high in HeLa cell mtDNA, whereas rAMPs and
rGMPs were the most abundant in a human fibroblast cell
line (12). Why the embedded ribonucleotides are better tol-
erated by mtDNA than nuclear DNA is not completely un-
derstood, although, possible explanations are the small size
of the mitochondrial genome, the slow rate of mtDNA syn-
thesis (13) and the bacteriophage-like enzymes involved in
its replication (PEO1, POLGand POLRM) (14).Moreover,
several outstanding questions remain: (i) What is the up-
per limit for ribonucleotides in mammalian mitochondrial
DNA? (ii) Does this threshold differ among the four bases?
(iii) What is the variation in rNMPs among different cell
and tissue types? (iv) Do incorporated ribonucleotides play
a role in mtDNA diseases?
To address these questions we employed emRiboSeq (15),
which makes use of type 2 RNase H cleavage at embedded
ribonucleotides in isolated genomicDNA.We establish that
ribonucleotide incorporation in mtDNA is much higher in
solid tissues than in proliferating cells, with rAMPs rep-
resenting over three-quarters of the total, from which we
infer ATP to be the major source of incorporated ribonu-
cleotides of mammalian mtDNA in vivo. However, this
changes markedly in mice lacking Mpv17, where rGMP
misincorporation increases, and in some cases becomes the
preponderant embedded ribonucleotide. The change is as-
sociated with both mtDNA depletion and multiple dele-
tions, suggesting that aberrant rGTP incorporation can
reach levels that impair mtDNA replication, resulting in
pathology.
MATERIALS AND METHODS
Animals and genotyping
CFW-Mpv17/J strain from Jackson laboratory (original
stock number 002208) was backcrossed to C57Bl/6J back-
ground using the Marker-Assisted Accelerated Backcross-
ing (MAX-BAX®) provided by Charles River to gener-
ate 100% of C57Bl/6J within 10 generations. The congenic
strain generated is identified as B6.CFW-Mpv17/J. Ani-
mals were genotyped by PCR, as described in (5). This re-
search has been regulated under theAnimals (Scientific Pro-
cedures) Act 1986 Amendment Regulations 2012 following
ethical review by the University of Cambridge Animal Wel-
fare and Ethical Review Body (AWERB) and the Francis
Crick Institute, Mill Hill Laboratory (FCI-MH).
Mitochondrial isolation, nucleotide pool determination and
DNA purification
Mitochondria were isolated from liver or brain and nu-
cleotides were extracted from 500 g aliquots of the mito-
chondrial preparation as previously described (5). Briefly,
proteins from each mitochondrial pellet were precipitated
with 0.5 M trichloroacetic acid and centrifuged at 20
000 × g for 5 min at 4◦C. Supernatants were neutral-
ized with 1.5 volumes of 0.5 M trioctylamine in Freon
(1,1,2-trichlorotrifluoroethane) and centrifuged for 10 min
at 10 000 × g at 4◦C. The upper phase, containing nu-
cleotides, was vacuum dried and stored at −80◦C until
analysis; dNTP concentrations were determined by a DNA
polymerase-based method, as described in (16). For NTPs
determination, nucleotides were extracted using methanol.
Briefly, aliquots of isolated mitochondria were resuspended
in cold 80% methanol, vortexed and incubated at −80◦C
for 4 h. Extracts were then centrifuged (16 000 × g for 10
min at 4◦C) and supernatants were vacuumdried and stored
at −80◦C until analysis. NTP pools were estimated using
T7 RNA polymerase incorporation of 32P-UTP (Perkin-
Elmer), according to the manufacturer’s instructions (Am-
bion) with PCR product corresponding to nucleotide po-
sition (np) 15890-168(T7) of murine mtDNA as template.
One reaction (the reference) contained the other 3 NTPs,
whereas other reactions lacked one of CTP, GTP or ATP
but included the same lyophilate used in the DNA poly-
merase assay. For mtDNA purification isolated mitochon-
dria were resuspended in 1.6 ml/g lysis buffer (20 mM
HEPES pH 7.8, 75 mM NaCl, 50 mM EDTA and 200
g/ml Proteinase K) on ice. After 10 min SDS was added
to 0.25% (w/v) and incubated at room temperature for 50
min; mtDNA was isolated by phenol–chloroform extrac-
tion. For the detection of multiple deletions by Southern
blot and mtDNA quantification, total DNA was extracted
from 100 mg of brain, liver or heart. Minced tissues were
lysed in 5 mM EDTA, 200 mM NaCl, 100 mM Tris, 0.2%
SDS. After addition of 200 g/ml of Proteinase K, samples
were incubated at 56◦C for 2 h and total DNAwas extracted
with phenol–chloroform.
DNAmodification, fractionation and Southern hybridization
For alkaline treatment 1 g of mtDNA purified by sucrose
gradient was treated eitherwith 100mMNaOH for the indi-
cated times or RNase H2 (in-house preparation) andMung
Bean Nuclease (New England Biolabs). DNA samples were
loaded directly on 1 X Tris-borate EDTA, 1% agarose gels
or first denatured at 95◦C for 3 min. For the detection of
multiple deletions 3 g of total DNA was digested with an
mtDNA single cutter (BglII) and loaded on a 0.6% TBE–
agarose gel. After electrophoresis, 250 mA for 4 h, gels were
washed either in 10 × SSC (for denatured samples) or 400
mM NaOH for 15 min twice (for non-denatured samples),
blot transferred to nylon membrane overnight and then UV
cross-linked, total energy 1200 × 100 J/cm2. Membranes
were pre-hybridized with 10 ml of hybridization solution (2
× SSPE, 2% SDS, 6×Denhardts reagent, 5% Dextran Sul-
fate) for 30 min at 55◦C. Riboprobes were synthesized from
PCR products incubated with ATP, CTP, GTP and -32P-
UTP and T7 RNA polymerase at 20◦C for 2 h (Ambion
Maxiscript T7 In vitro Transcription Kit). After overnight
hybridization at 55◦C themembrane was washed repeatedly
with 0.1 × SSPE, 0.5% SDS until there was no signal in the
wash solution and exposed to X-ray film.
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Primer sequences used to generate PCR products for ribo-
probe synthesis
The T7 promoter sequence is underlined.
nt (strand) Sequence 5′-3′
300 (L) ATTTCGTGCCAGCCACCGCGGTCATACGAT
T7 1000 (H) TAATACGACTCACTATAGGGGTATGCTT
T7 14881 (L) TAATACGACTCACTATAGGTCCCAGACATAC
TAGGAGACCCA
15800 (H) AAGAACCAGATGTCTGATAAAGTTTC
15490 (H) CTTGGGGAAAATAGTTTAATGTACG
T7 15750 (L) TAATACGACTCACTATAGGATTAAACTTG
GGGGTAGCTAAAC
16299 (H) TTGTTAATGTTTATTGCGTAATAGAGT
340 (H) GTTTGGGTTAATCGTATGACCG
Quantification of mtDNA copy number
Relative amount of mtDNA was measured by real-time
quantitative PCR as described in (5), with some modifi-
cations. Reactions were performed in triplicates on 384-
well reaction plates (Applied Biosystems). Each PCR re-
action had a final volume of 10 l and contained 20 ng
DNA, 5 l of Power SYBR-Green PCR Master Mix (Ap-
plied Biosystems) and 0.5 M of forward and reverse
primers. Regions of Cox2 and App1 were amplified as mi-
tochondrial and nuclear gene references, respectively, using
the following primers:Mm-COXII-F: GAGCAGTCCCCT
CCCTAGGA, Mm-COXII-R: GGTTTGATGTTACTGT
TGCTTGATTT, Mm-APP1-F: CGGAAACGACGCTC
T CATG, Mm-APP1-R: CCAGGCTGAATTCCCCAT.
Changes in mtDNA amount were calculated using the
2−Ct method (17) and represented as fold changes rela-
tive to the indicated control.
Liver protein preparation and immunoblotting
Liver samples were homogenised in buffer consisting of 10
mM Tris–HCl pH 7.5, 1 mM EGTA, 75 mM sucrose, 225
mM sorbitol and 0.1% BSA, before lysis at 4◦C in 50 mM
Tris–HCl pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% NP40,
0.1% SDS and 1× protease inhibitor cocktail (Roche). Pro-
tein concentration was determined by Lowry assay (DC
Reagent, Bio-Rad), and 5 g of protein resolved on PAGE
gels (Novex) before transfer to Imobilon-Pmembrane (Mil-
lipore). Following blocking with 5% non-fat dry milk in
PBS with 0.1% (v/v) Tween-20, membranes were incubated
overnight with the following primary antibodies: mouse
anti-NDUFB8 (1:10 000, Abcam AB110242), mouse anti-
COX IV (1:10 000, Abcam AB14744), rabbit anti-MPV17
(1:1000, Proteintech 10310-1-AP) or rabbit anti-TOM20
(1:20 000, Santa Cruz Biotechnology SC-11415). Mem-
branes were incubated with HRP-conjugated anti-mouse
or anti-rabbit secondary antibody (1:4000, Promega) in 5%
non-fat dry milk in PBS with 0.1% (v/v) Tween-20, and
visualised using enhanced chemiluminescence (ECL, G.E.
Healthcare).
EmRiboSeq library preparation
20 g of total nucleic acid was treated with 2.5 g RNase A
(Invitrogen 46-7604) in 400 mMNaCl for 1 h at room tem-
Figure 1. MammalianmtDNA from solid tissues is more sensitive to alkali
than that of proliferating cultured cells. DNA from isolated mitochondria
of human 143B cells, human placenta, murine LA9 cells and mouse liver
was fractionated by 1D-AGE, after exposure to 100 mM sodium hydrox-
ide (NaOH) for the indicated times, and blot hybridized to radiolabeled
probes corresponding to segments of human (16 343–151) or murine (15
007–15 805) mtDNA. oc – open circlular, sc – supercolied, and ds – double
stranded, ss – single stranded mtDNA. Treatments with type 2 RNase H
fragmented the murine liver mtDNA to a similar extent (Supplementary
Figure S1), indicating that most alkali sensitive sites are rNMPs and not
abasic sites.
perature and fragmented using Covaris sonication (duty cy-
cle: 10%, intensity: 5, cycles/burst: 200, time: 120 s at 4◦C),
after which the DNA was ethanol precipitated and used for
library preparation, according to Ding et al. (15), with the
following modifications: AMPure XP beads were removed
after each clean-up step, to increase yield, and the final E-
gel based size-selection step was omitted.
Genomic mapping strategy
Mapping of reads was performed largely as previously de-
scribed (15). To allow unique mapping of mitochondrial
reads, high identity nuclear inserted mitochondrial derived
sequences were N-masked in the mm9 reference genome.
The reference chrM sequences was aligned by blast to the
reference genome requiring high identity matches (match-
score > 100, identity > 95%). All identified matching seg-
ments (excepting chrM itself) were N-masked in the refer-
ence. The same filtering approach was applied to reference
genome segments matching the rDNA reference fragment
and the rDNA reference sequence included with the mm9
genome for mapping. To allow unbiased mapping of reads
over the ends of the artificially linearized chrM sequence
in the reference assembly, a second version of the reference
assembly was prepared containing the concatenated circu-
larisation junction with 200nt flank on both sides and the
corresponding sequences masked from the chrM sequence
(the mm9chrMcirc genome). Ion Proton single end reads
were clipped of residual adaptor sequence using cutadapt
(options: overlap = 12 minimum-length = 30 and adap-
tor ‘a’ set to ATCACCGACTGCCCATAGAGAGG). Af-
ter clipping, reads were aligned separately to the mm9 and
mm9chrMcirc genomes using Bowtie2 (version 2.2.6). In
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Figure 2. rAMP is the dominant ribonucleotide inmtDNAofmurine solid
tissues, the combined result of nucleotide concentrations and the properties
of POLG. (A) The proportion of each of the embedded rNMPs in murine
liver, brain and heart mtDNA and the base composition of the ‘primary
sequence’ of the mouse mitochondrial genome (ChrM). (B) Expected pro-
portions of embedded rNMPs if the sole determinant were: (i) the mtDNA
base composition, (ii) the rNTP/dNTP ratio in livermitochondria (derived
from (20)), (iii) the discrimination factor (DF) of the mitochondrial DNA
polymerase (POLG) (derived from (21)), both adjusted for the mtDNA se-
quence; or (iv) if rNMP incorporation was a function of both the POLG
DF and the rNTP:dNTP ratio. This ‘composite’ is most similar to the ob-
served proportions for liver (v).
the case of reads discordantly mapped between the mm9
and mm9chrMcirc genome the alignment with the high-
est mapping quality score were retained and coordinates
of read 5′ ends transformed into mm9 coordinates. Except
where otherwise stated, only reads with a phred-scaled map
quality score of ≥30 were used for subsequent analysis.
Read alignment extraction and filtering performed by Sam-
tools (version 1.2). Embeded ribonucleotide positions were
inferred as the nucleotide upstream and on the opposite
strand of the read 5′ mapped end. Coordinate transforms
Figure 3. rGMP replaces rAMP as the predominant embedded ribonu-
cleotide in mtDNA in the liver of the Mpv17 knockout mouse. (A) Alkali
(NaOH) fragmentation of liver mtDNA from wild-type (WT) and Mpv17
knockout (KO) mice analyzed by agarose gel electrophoresis and South-
ern hybridization with probes to np 4000–8120 (probe a) and 14881–16299
(probe b); MBN – mung bean nuclease treatment. (B) The proportion and
(C) the distribution (enlarged in Supplementary Figures S4 and S8) of the
rNMPs in murine liver mtDNA with (WT) or lacking (KO) the Mpv17
gene.
and signal counting were performed using bedtools (ver-
sion 2.26). The complete processing pipeline from FASTQ
to Bed files of embedded nucleotides and derived figures is
available at https://github.com/taylorLab/mito.
Genomic composition
To calculate a relative rate of ribonucleotide incorporation
we need to correct of genomic sequence composition. How-
ever, due to the repetitive nature of the genome and the
necessity to filter on alignment quality, a substantial and
compositionally biased portion of the genome cannot be
mapped uniquely. Accounting for this, all segments of the
reference genome that are uniquelymappable (GRCmappa-
bility100 mm9 track from UCSC) were extracted (bedtools
getfasta) and their nucleotide and trinucleotide composi-
tions calculated. Trinucleotide context was calculated for
each identified riboincorporation site, where the ribo was
the central of the three nucleotides on the ribo-containing
strand.
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Sequencing library preparation and analysis
For the sequencing analysis, mouse brainmtDNAwas puri-
fied from sucrose-gradient isolated mitochondria as above.
Purified mtDNA was fragmented prior to library prepa-
ration as previously (5). 200 bp paired-end DNA libraries
were prepared using the Illumina TruSeq LT kit and run on
the MiSeq. Sequencing data (FASTQ) files were mapped to
the MT mm9 assembly and the reads mapped using BWA
(Burrows-Wheeler Aligner) software (Li (2013)) Aligning
sequence reads, clone sequences and assembly contigs with
BWA-MEM. arXiv:1303.3997), version bwa-0.7.8, bwa-
mem algorithm with default parameters. The mapped read
(sam) files were then converted to bam format using sam-
tools version 0.1.19 (18). The reads in each bam file were
sorted and indexed using samtools. Finally, the two bam
files from different sequencing runs for each sample were
merged using Picard tool MergeSamFiles. Coverage and
mutation loads were calculated as previously (5).
Statistical analysis
Data analysis and figure plotting was performed in R (ver-
sion 3.4.1) utilising standard libraries and the rollapply
function from the Zoo package (19). A complete set of R
analysis and plotting code is available at https://github.com/
taylorLab/mito. For mtDNA and dNTPs pool size, data
are expressed as the mean ± standard error of the mean
(SEM). Group means were compared using parametric t-
test or non-parametric Mann-Whitney test. P < 0.05 was
considered as statistically significant.
RESULTS
Ribonucleotide incorporation in mtDNA is substantially
higher in solid tissues than cultured cells
Most studies of the presence of ribonucleotides in mtDNA
have used material from cultured cells (7,9,12). To deter-
mine whether the ribosubstitution of mammalian mtDNA
is a general phenomenon and therefore also present in vivo,
human placenta andmurine solid tissues, as well as cultured
cells (mouse LA9 and human 143B osteosarcoma cells)
were subjected to alkali or type 2 RNase treatment. The as-
says confirmed the presence of numerous rNMPs scattered
throughout the molecules (Figure 1, Supplementary Figure
S1), and showed that the fragmentation was more marked
for the mtDNA of solid tissues than for proliferating cells
(Figure 1), indicating that ribosubstitution of mtDNA is
considerably more prevalent in vivo, in post-mitotic tissues.
rAMP dominates as the most abundant ribosubstitution
throughout both strands of mtDNA of murine solid tissues
To determine the identity and distribution of ribonu-
cleotides in mtDNA we performed deep sequencing of em-
RiboSeq libraries of purified murine liver mtDNA, pre-
pared according to (15) (see Supplementary Figure S2
for details and validation). Alignment of tens of millions
of reads to the mitochondrial genome revealed marked
differences among the four ribonucleotides. Overall more
than 80% of all ribonucleotides embedded in murine liver
Figure 4. Elevated embedded rGMPs in mtDNA of brain and heart from
Mpv17 null mice, without altered dNTP pools or mtDNA copy num-
ber. (A) Mitochondrial (mt) DNA copy number in brain and heart of
Mpv17−/− mice (gray) relative to controls (WT), n= 3 independent exper-
iments, t-test; and (B) Brain mitochondrial dNTP pools in control (black)
andMpv17−/− (gray) animals of 8–10weeks of age. P values were obtained
using Mann-Whitney test (n = 4). Not significant (ns) P > 0.05. Data are
expressed as mean± SEM. (C) Relative frequency of incorporated ribonu-
cleotides of heart and brain mtDNA of Mpv17 KOmice of 2–3 months of
age determined by emRiboSeq represented as pie charts; rA – rAMP, rC –
rCMP, rG – rGMP, rU – rUMP/rTMP.
mtDNA identified were rAMPs, disproportionate to the
number of adenine bases present in the murine mitochon-
drial genome; and rAMPs also outnumbered the other rN-
MPs in brain and heart mtDNA (Figure 2A). Thus, rAMPs
are the predominant ribosubstitution event in the mtDNA
of solid tissues. In contrast, analysis of nuclear DNA reads
present in the same emRiboSeq libraries showed that there
was no appreciable bias towards a particular rNMP in the
nuclear genome of murine liver or that of mouse embryonic
fibroblasts (MEF) (Supplementary Figures S3A and B).
MEFmtDNA also did not display the pronounced prepon-
derance of rAMPs seen in solid tissue (Supplementary Fig-
ure S3C). In mtDNA, the rNMPs were widely distributed
across both strands (Supplementary Figure S4A), with the
precise distribution being influenced partially by the trinu-
cleotide context (Supplementary Figure S4B and S4C). Al-
though there appeared to be some pronounced regional bi-
ases, these were largely attributable to low mapping quality,
owing to truncated reads (Supplementary Figure S5).
The heavy bias towards rAMPs in solid tissue is read-
ily explained by the high ATP level in mitochondria (20),
predicting a skew away from equality and heavily towards
rAMP incorporation (Figure 2B-i compared to 2B-ii). Be-
sides the nucleotide pool sizes, the incidence of embed-
ded ribonucleotides in mtDNA is affected by the ability
of the replicative polymerase to discriminate deoxyribonu-
cleotides from ribonucleotides, the discrimination factor of
the enzyme (21). In the case of mtDNA polymerase POLG,
this measure would predict rGMP to be the most frequently
incorporated rNMP (Figure 2B-iii). The composite of the
two predictions yields a pattern very much in line with the
results of the emRiboSeq analysis (Figure 2B-iv versus B-v)
and thus the representation of the different ribonucleotides
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inmtDNAofmurine solid tissues (Figure 2A) can largely be
explained by the concentrations of the different rNTPs rela-
tive to dNTPs inside mitochondria, coupled with the ability
of POLG (and the otherDNApolymerases inmitochondria
(22,23)) to discriminate each dNTP from its rNTP counter-
part.
rGMP replaces rAMPas the predominant ribonucleotide em-
bedded in mtDNA in Mpv17 deficient mouse liver
Having established that the rNTP:dNTP ratio is an impor-
tant determinant of the ribosubstitution rate of mtDNA,
we predicted that any increase in this ratio will lead to an in-
crease in the ribonucleotides incorporated in mtDNA. This
hypothesis was tested in the liver of the Mpv17 deficient
mouse, which displays OXPHOS deficiency, decreased mi-
tochondrial dNTP pools and mtDNA depletion ((5) and
Supplementary Figure S6). The total amount of embed-
ded rNMPs was similar to that of controls in the livers
of Mpv17 knockout mice, based on the alkali fragmen-
tation assay (Figure 3A), but there was a substantial in-
crease in rGMP incorporation based on emRiboSeq anal-
ysis (Figure 3B). These observations could be explained by
an increased rGTP:dGTP ratio, as livermitochondria of the
Mpv17 null mouse show a marked reduction in the level
of dGTP, alongside an expected decreased ATP:dATP ra-
tio owing to reduced mitochondrial ATP production as a
result of OXPHOS deficiency (Supplementary Figure S6).
Notwithstanding this, findings from other tissues of the
Mpv17−/− mouse indicated that this model needed to be
further refined.
Normal mtDNA copy number and dGTP levels, but elevated
rGMP incorporation in Mpv17 deficient brain
Brain and heart of the Mpv17 ablated mice maintained
mtDNA copy number at normal levels (Figure 4A), and
dNTP concentrations in the brain mitochondria were com-
parable to controls (Figure 4B). Furthermore, sequencing
of brain mtDNA indicated no increase in the error rate for
dNMPs (Supplementary Table S1). However, the propor-
tion of rGMPs embedded in the mtDNA increased 2–4-fold
in brain and heart of the Mpv17−/− mice (Figure 4C). Al-
though raised rGTP levels could also lead to an elevated
rGTP/dGTP ratio and consequent increase in rGMP incor-
poration, there was no significant increase in the concentra-
tion of rGTP in mitochondria of either an affected (liver) or
an unaffected tissue (kidney), based on anRNApolymerase
extension assay (Supplementary Figure S7). These findings
suggest that high levels of embedded rGMPs in mtDNAoc-
cur as a consequence of Mpv17 deficiency in every tissue,
irrespective of the overall nucleotide pool sizes.
Late onset multiple deletions of mtDNA in brain of Mpv17
null mice
Elevated rGMP incorporation is a pronouncedmtDNA ab-
normality of Mpv17 deficient mice (Figures 3 and 4); if it
is pathological, mtDNA abnormalities less extreme than
depletion may occur in tissues other than liver. Based on
the human disorders, brain is expected to be the second
Figure 5. Multiple deletions that are synonymous with DNA replication
stalling are detected in the brain of Mpv17 null mice of 12 months of age.
(A) Southern blot of brain DNA of mice aged 1 year hybridized with a
probe to np 14881–16299 of the murine mitochondrial genome. Wild-type
mice (WT) andMpv17 knockout animals (KO). Note the more prominent
smear of linear deleted molecules below the full length mtDNAs in the KO
samples. (B) dNTP levels in brain mitochondria of Mpv17 KO mice aged
2–3 months or 10–12 months, expressed relative to age matched controls, n
= 4. P values were obtained using Mann-Whitney test (NS, not significant
P>0.05).
most vulnerable tissue of the Mpv17 ablated mouse, and
late-onset multiple deletions of mtDNA the likely defect
(6,24,25). Therefore, mtDNA of 12-month-old Mpv17−/−
mice was analyzed by Southern hybridization and multi-
ple deletions of mtDNA, not evident in age-matched lit-
termates controls, were detected (Figure 5A), while dNTP
levels in brains of both young and old Mpv17−/− animals
remained within the normal range (Figure 5B). We there-
fore establish that in spite of normal overall dNTP levels,
rGMP incorporation in brain mtDNA is elevated inMpv17
knockout mice, and that this is accompanied by late-onset
mtDNA deletions.
DISCUSSION
Our analysis of embedded ribonucleotides in mtDNA of
solid tissues indicates that although the discrimination fac-
tor of the mitochondrial DNA polymerase contributes to
the observed ribonucleotide incorporation patterns (12),
the rNTP:dNTP ratio is the single most important determi-
nant in the ribosubstitution of mature mammalian mtDNA
(Figures 1–3). Moreover, the markedly lower ribosubsti-
tution frequency of mtDNA of cultured cells compared
to solid tissues (Figure 1) can also be attributed to the
rNTP:dNTP ratio, as cycling cells require high concentra-
tions of dNTPs to support nuclear DNA replication (26).
Evidently, the presence of riboadenosines in the mtDNA of
solid tissues is well tolerated. It is plausible that over the
course of time, evolutionmay have exploited the presence of
riboadenosines in mtDNA of solid tissues. For example, as
embedded rAMPs produce subtle changes in the structure
of the phosphodiester backbone (27) their presence might
facilitate or discourage interactions with nucleic acid bind-
ing proteins.
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MPV17 function, rGMPs and disease mechanism
The normal level of dGTP in the brain of the Mpv17
knockout mouse argues against the protein being involved
in dNTP synthesis or import into mitochondria. Never-
theless, the weight of evidence still points to guanosine
metabolism being critical to the MPV17-related disorder.
Clinically, MPV17 deficiency is most similar to diseases
caused by mutations in deoxyguanosine kinase (DGOUK),
with both giving rise to hepato-cerebral syndromes (6,28).
Moreover, zebrafish lose their stripes of crystallized guanine
whenMpv17 is scarce (29). The data presented here further
contribute that rGMP incorporation is a general aberrant
feature of mammalian mtDNA in the absence of Mpv17
(Figures 3 and 4) and strongly supports the earlier conclu-
sion that alteration of nucleotide homeostasis underlies the
pathogenesis of MPV17-related disease (5). Three mecha-
nisms of action can be envisaged for Mpv17 to explain the
high level of rGMP in mature mtDNA, all of which involve
the protein facilitating the supply of (pristine) dGTP to the
replisome: i) Mpv17 alters the discrimination properties of
POLG, leading to increased misincorporation of rGTP, al-
though there is currently no evidence that the two proteins
interact (30); ii) sanitation of dNTPs is an important func-
tion for nuclear DNA replication (31), hence, Mpv17 might
sanitize dGTP, and in its absence, while dGTP levels are
normal, many more damaged forms are presented to the
replicative DNA polymerase, increasing the use of rGTP
as an undamaged alternative; or iii) Mpv17 influences the
concentration of dNTPs in the vicinity of the replisome, in
particular dGTP. One or more proteins are expected to have
such a function, because a means of concentrating dNTPs
where they are needed would greatly reduce the demand on
deoxynucleotide biosynthesis for mtDNA replication and
minimize misincorporation of ribonucleotides, while simul-
taneously reducing dNTP interference with the many pro-
cesses utilizing rNTPs.
That elevated rGMP is the primary abnormality of the
mtDNA of Mpv17 deficient mice suggests that these in-
corporated ribonucleotides are fundamental to the disease.
Even a single rGMP in a template slows the rate of synthe-
sis of POLG in vitro (21), and embedded rGMP distorts the
double helix substantially and affects melting temperature
(27,32). Each of these factors could increase the probabil-
ity of DNA replication stalling, and thus at the high rGMP
levels reached in some solid tissues or cell types lead to an
accumulation of stalled replication intermediates, evident as
multiple deletions ofmtDNA. In extremis, dNTPpoolsmay
be adjusted to slow replication andmitigate the stalling, but
at the cost of mtDNAdepletion (illustrated schematically in
Figure 6).
The striking changes in ribonucleotide incorporation in
mtDNA associated with Mpv17 deficiency raise the ques-
tion of whether this abnormality might explain other cur-
rently obscure causes of mtDNA disease. For example, mu-
tations in the adenine nucleotide transporter (ANT1) were
the first identified cause of mtDNA deletions (33), yet a
molecular explanation is still lacking. If the pathological
ANT mutants lead to elevated ATP levels, particularly in
the vicinity of replicating mtDNAs, then this could push
embedded rAMPs to deleterious levels. Hence, many as-
Figure 6. Model of diseasemechanism forMPV17 deficiency. Loss of func-
tion of MPV17 in humans and mice results in multiple deletions and de-
pletion of mtDNA. In mice, high levels of embedded rGMPs are a pro-
nounced mtDNA abnormality that appears to be an unavoidable conse-
quence of Mpv17 deficiency, which, we propose, is the result of changes
in the local ratio of rGTP/dGTP. The exact level of embedded rGMPs is
expected to depend on tissue specific features of nucleotide metabolism
and the rates of mtDNA synthesis and turnover, but whenever rGMPs
exceed a certain threshold it impedes DNA replication causing stalling,
manifesting as multiple deletions (s), as seen in the brain of 12-month
old Mpv17−/− mice. Worsening of the problem would be expected to lead
eventually to complete replication arrest. Therefore, we interpret the low-
ering of the dGTP and dTTP pools (this report and (5)), as an adjustment
of dNTP pools towards equality, to slow replication and improve fidelity
(5,34), that allows some functional mtDNA molecules to be maintained
indefinitely, as seen in the liver of Mpv17 knockout mice (35).
pects of mitochondrial DNA disorders need to be reconsid-
ered in light of the fact that a striking abnormality, embed-
ded ribonucleotides, has hitherto been largely overlooked.
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